JLHL Jupiter Life Line Hospitals Q4 FY26 results (Jan–Mar 2026) and concall
Jupiter Life Line Hospitals reported robust financial performance for Q4 and FY26, with double-digit revenue and EBITDA growth. The company successfully launched its Dombivli greenfield hospital ahead of schedule and within budget, while progressing other expansion projects. Operational metrics like ARPOB and occupancy rates showed healthy trends, and the company maintained a net cash positive position despite significant capital expenditure for its ambitious expansion plans.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 13.9%, net profit up 11.4% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 270 | 274 | 278 | 316 | 291 +8% | 312 +14% |
| EBITDA | 69 | 72 | 68 | 79 | 76 +10% | 78 +8% |
| Net profit | 49 | 44 | 43 | 55 | 44 −10% | 49 +11% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
